PMO-241 Conveying Medication Benefits to Ulcerative Colitis Patients: What Thresholds for Adherence Are Applied?

Gut - United Kingdom
doi 10.1136/gutjnl-2012-302514b.241
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Fecal Bacteriotherapy for Ulcerative Colitis: Patients Are Ready, Are We?

Inflammatory Bowel Diseases
AllergyImmunologyGastroenterology
2012English

Medication Adherence and Persistence in the Treatment of Canadian Ulcerative Colitis Patients: Analyses With the RAMQ Database

BMC Gastroenterology
MedicineGastroenterology
2013English

Working With Patients to Enhance Medication Adherence

Clinical Diabetes
Internal MedicineEndocrinologyMetabolismDiabetes
2008English

Adherence to Medication

International Journal of Research in Ayurveda and Pharmacy
Drug DiscoveryPharmaceutical Science
2013English

Ileostomy for Ulcerative Colitis

BMJ
1942English

Treatment for Ulcerative Colitis

Okayama Igakkai Zasshi (Journal of Okayama Medical Association)
2010English

Benefits of Elective Laparoscopic 2-Stage Restorative Proctocolectomy for Ulcerative Colitis in Korea

Annals of Coloproctology
Gastroenterology
2020English

Editorial: Tofacitinib and Biologics for Moderate-To-Severe Ulcerative Colitis-What Is Best in Class?

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Ulcerative Colitis

Radiographics
MedicineNuclear MedicineRadiologyImaging
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy